Related Experiment Video
Updated: Jun 12, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Effect of Peptide-Chelate Architecture on Metabolic Stability of Peptide-based MRI Contrast Agents
Zhaoda Zhang1, Andrew F Kolodziej, Jianfeng Qi
1A. A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, 149 Thirteenth St, Suite 2301, Charlestown, MA 02129, USA.
Abstract:
A strategy for preparing high relaxivity, metabolically stable peptide-based MR contrast agents is described.
More Related Videos
11:27Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
13:21Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
Published on: July 21, 2011
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Complexation Equilibria: The Chelate Effect